Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis - PubMed (original) (raw)
Review
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Quentin M Anstee et al. Nat Rev Gastroenterol Hepatol. 2013 Jun.
Abstract
NAFLD is a spectrum of progressive liver disease that encompasses simple steatosis, NASH, fibrosis and, ultimately, cirrhosis. NAFLD is recognized as the hepatic component of the metabolic syndrome, as these conditions have insulin resistance as a common pathophysiological mechanism. Therefore, NAFLD is strongly associated with type 2 diabetes mellitus and abdominal obesity. As lifestyles have become increasingly sedentary and dietary patterns have changed, the worldwide prevalence of NAFLD has increased dramatically and is projected to be the principal aetiology for liver transplantation within the next decade. Importantly, a growing body of clinical and epidemiological evidence suggests that NAFLD is associated not only with liver-related morbidity and mortality, but also with an increased risk of developing both cardiovascular disease and type 2 diabetes mellitus. This article reviews the evidence that suggests NAFLD is a multisystem disease and the factors that might determine interindividual variation in the development and progression of its major hepatic and extrahepatic manifestations (principally type 2 diabetes mellitus and cardiovascular disease).
Similar articles
- Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease.
Canbay A, Kachru N, Haas JS, Sowa JP, Meise D, Ozbay AB. Canbay A, et al. Aliment Pharmacol Ther. 2020 Oct;52(7):1185-1194. doi: 10.1111/apt.16016. Epub 2020 Aug 17. Aliment Pharmacol Ther. 2020. PMID: 33016540 - Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA, Vere CC, Rogoveanu I, Streba CT. Streba LA, et al. World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103. World J Gastroenterol. 2015. PMID: 25892859 Free PMC article. Review. - Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
Satapathy SK, Sanyal AJ. Satapathy SK, et al. Semin Liver Dis. 2015 Aug;35(3):221-35. doi: 10.1055/s-0035-1562943. Epub 2015 Sep 17. Semin Liver Dis. 2015. PMID: 26378640 Review. - [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
Zhu C, Zhou D, Fan J. Zhu C, et al. Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):81-4. doi: 10.3760/cma.j.issn.1007-3418.2016.02.001. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 26983471 Chinese. - Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes.
Doycheva I, Patel N, Peterson M, Loomba R. Doycheva I, et al. J Diabetes Complications. 2013 May-Jun;27(3):293-300. doi: 10.1016/j.jdiacomp.2012.10.008. Epub 2013 Jan 9. J Diabetes Complications. 2013. PMID: 23312215 Free PMC article. Review.
Cited by
- The novel TFEB agonist desloratadine ameliorates hepatic steatosis by activating the autophagy-lysosome pathway.
Lin J, Huang C, Zhao J, Li L, Wu Z, Zhang T, Li Y, Li W, Guo B, Liu Z, Diao A. Lin J, et al. Front Pharmacol. 2024 Sep 18;15:1449178. doi: 10.3389/fphar.2024.1449178. eCollection 2024. Front Pharmacol. 2024. PMID: 39359254 Free PMC article. - Fibrosis-4 Score Is Associated with Mortality in Hemodialysis Patients with Chronic Viral Hepatitis: A Retrospective Study.
Liu HH, Yen CL, Jeng WJ, Hung CC, Hsiao CC, Tian YC, Chen KH. Liu HH, et al. Diagnostics (Basel). 2024 Sep 15;14(18):2048. doi: 10.3390/diagnostics14182048. Diagnostics (Basel). 2024. PMID: 39335727 Free PMC article. - The Predictive Value of Time-Varying Noninvasive Scores on Long-Term Prognosis of NAFLD in South Korea.
Chung SW, Park MK, Zhang X, Wang T, Jemielita T, Fernandes G, Engel SS, Jang H, Lee YB, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ. Chung SW, et al. Can J Gastroenterol Hepatol. 2024 Sep 16;2024:5667986. doi: 10.1155/2024/5667986. eCollection 2024. Can J Gastroenterol Hepatol. 2024. PMID: 39314528 Free PMC article. - Non-linear associations between cardiovascular metabolic indices and metabolic-associated fatty liver disease: A cross-sectional study in the US population (2017-2020).
Xu M, Han S, Wu Q, Ma S, Cai H, Xue M, Liu F, Xiao X, Chen X, Lin M. Xu M, et al. Open Life Sci. 2024 Sep 10;19(1):20220947. doi: 10.1515/biol-2022-0947. eCollection 2024. Open Life Sci. 2024. PMID: 39290497 Free PMC article. - Exploring the Relationship of rs2802292 with Diabetes and NAFLD in a Southern Italian Cohort-Nutrihep Study.
Forte G, Donghia R, Lepore Signorile M, Tatoli R, Bonfiglio C, Losito F, De Marco K, Manghisi A, Guglielmi FA, Disciglio V, Fasano C, Sanese P, Cariola F, Buonadonna AL, Grossi V, Giannelli G, Simone C. Forte G, et al. Int J Mol Sci. 2024 Sep 1;25(17):9512. doi: 10.3390/ijms25179512. Int J Mol Sci. 2024. PMID: 39273459 Free PMC article.
References
- Nat Rev Endocrinol. 2011 May 10;7(8):456-65 - PubMed
- Eur J Endocrinol. 2009 Apr;160(4):593-602 - PubMed
- Nature. 2012 Feb 01;482(7384):179-85 - PubMed
- Diabetes Care. 2012 Feb;35(2):389-95 - PubMed
- J Hepatol. 2010 Aug;53(2):372-84 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials